Cargando…

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance

BACKGROUND: Estimates of the prevalence of transmitted HIV drug resistance (TDR) in a population are derived from resistance tests performed on samples from patients thought to be naïve to antiretroviral treatment (ART). Much of the debate over reliability of estimates of the prevalence of TDR has f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro, Hannah, Pillay, Deenan, Sabin, Caroline, Dunn, David T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364874/ https://www.ncbi.nlm.nih.gov/pubmed/22416878 http://dx.doi.org/10.1186/1471-2288-12-30

Ejemplares similares

Persistence of HIV-1 Transmitted Drug Resistance Mutations
por: Castro, Hannah, et al.
Publicado: (2013)

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance
por: Gifford, Robert J., et al.
Publicado: (2009)

Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
por: Zhao, Shuai, et al.
Publicado: (2018)

Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy
por: Huntington, Susie, et al.
Publicado: (2015)

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2016)

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
por: Bennett, Diane E., et al.
Publicado: (2009)

Combination antiretroviral therapy and cell–cell spread of wild-type and drug-resistant human immunodeficiency virus-1
por: Titanji, Boghuma Kabisen, et al.
Publicado: (2017)

Misclassification of current status data
por: McKeown, Karen, et al.
Publicado: (2010)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children – a EuroCoord-CHAIN-EPPICC joint project
por: Ngo-Giang-Huong, Nicole, et al.
Publicado: (2016)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999–2014
por: Aldous, Annette M., et al.
Publicado: (2017)

Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
por: Phillips, Andrew, et al.
Publicado: (2014)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2011)

Transmitted antiretroviral drug resistance mutations in newly diagnosed HIV-1 positive patients in Turkey
por: Sayan, Murat, et al.
Publicado: (2014)

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom
por: White, Ellen, et al.
Publicado: (2016)

Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran
por: Memarnejadian, Arash, et al.
Publicado: (2015)

Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations
por: Kessler, Harald H, et al.
Publicado: (2019)

The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy
por: Huntington, Susie, et al.
Publicado: (2015)

Correction: National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2012)

Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011
por: Jahanbakhsh, Fatemeh, et al.
Publicado: (2013)

Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021
por: Su, Yifan, et al.
Publicado: (2023)

Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2014)

HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia
por: Kotaki, Tomohiro, et al.
Publicado: (2015)

Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea
por: Mbange, Aristid Ekollo, et al.
Publicado: (2018)

Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea
por: Lechat, Bastien, et al.
Publicado: (2021)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database
por: Ruelle, Jean, et al.
Publicado: (2008)

Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women
por: Huntington, Susie, et al.
Publicado: (2014)

Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
por: Xiaobai, Zou, et al.
Publicado: (2014)

The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China
por: Shen, Yuelan, et al.
Publicado: (2014)

Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil
por: Bahls, Larissa Danielle, et al.
Publicado: (2019)

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
por: Gupta, Ravindra K, et al.
Publicado: (2012)

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom
por: Tostevin, A, et al.
Publicado: (2016)

Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations
por: Monge, Susana, et al.
Publicado: (2014)

Prevalence of transmitted HIV-1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots
por: de Moraes Soares, Celina M P, et al.
Publicado: (2014)

Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
por: Martin, Supang A., et al.
Publicado: (2021)

Surveillance of Transmitted Antiretroviral Drug Resistance among HIV-1 Infected Women Attending Antenatal Clinics in Chitungwiza, Zimbabwe
por: Tshabalala, Mqondisi, et al.
Publicado: (2011)

Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort
por: Levintow, Sara N, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1as3pjtse6nigfrun7br8jdds7